Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Beyond weight, patients often enjoy increased energy, reduced joint discomfort, enhanced sleep, improved self-assurance, and decreased risk factors for heart disease, diabetes, and other obesity-linked conditions
NICE recommends using tools such as QRISK3 to estimate 10-year cardiovascular disease risk
Nausea and sleep disruption are another pathway
Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-nave patients with type 2 diabetes (SUSTAIN 4): A randomized, open-label, parallel-group, multicentre, multinational, phase 3a trial
Semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan, with no additional cost as your dose increasesyour dose may need to go up, but your price won't
